ArticleJournal of clinical microbiology2005
Use of resequencing oligonucleotide microarrays for identification of Streptococcus pyogenes and associated antibiotic resistance determinants.
Article in Journal of clinical microbiology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Multiplex detection and identification of viral, bacterial, and protozoan pathogens in human blood and plasma using an expanded high-density resequencing microarray platform.Frontiers in molecular biosciences · 2024Article
- DNA microarray analysis reveals that antibiotic resistance-gene diversity in human gut microbiota is age related.Scientific reports · 2014Article
- Article
- Multipurpose instantaneous microarray detection of acute encephalitis causing viruses and their expression profiles.Current microbiology · 2012Review
- Universal detection and identification of avian influenza virus by use of resequencing microarrays.Journal of clinical microbiology · 2009Article
- Resequencing arrays for diagnostics of respiratory pathogens.Methods in molecular biology (Clifton, N.J.) · 2009Article
- Resequencing microarray probe design for typing genetically diverse viruses: human rhinoviruses and enteroviruses.BMC genomics · 2008Article
- A model of base-call resolution on broad-spectrum pathogen detection resequencing DNA microarrays.Nucleic acids research · 2008Article
- Molecular characterization of Neisseria meningitidis isolates using a resequencing DNA microarray.The Journal of molecular diagnostics : JMD · 2008Article
- Applying rapid genome sequencing technologies to characterize pathogen genomes.Analytical chemistry · 2008Article
- Massively parallel pathogen identification using high-density microarrays.Microbial biotechnology · 2008Article
- Microarrays in infection and immunity.Current opinion in chemical biology · 2007Review
- Application of broad-spectrum, sequence-based pathogen identification in an urban population.PloS one · 2007Article
- Using a resequencing microarray as a multiple respiratory pathogen detection assay.Journal of clinical microbiology · 2007Article
- A bioinformatic filter for improved base-call accuracy and polymorphism detection using the Affymetrix GeneChip whole-genome resequencing platform.Nucleic acids research · 2007Article
- Microarray technology in obstetrics and gynecology: a guide for clinicians.American journal of obstetrics and gynecology · 2006Review
- Automated identification of multiple micro-organisms from resequencing DNA microarrays.Nucleic acids research · 2006Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Group A streptococci (GAS) are responsible for a wide variety of human infections associated with considerable morbidity and mortality. Ever since the first systematic effort by Lancefield to group Streptococcus species by M protein variants, the detection and characterization of Streptococcus by different methods have been an evolving process. The ideal assay for GAS identification not only would provide quick and accurate diagnostic results but also would reveal antibiotic resistance patterns and genotype information, aiding not only in treatment but in epidemiologic assessment as well. The oligonucleotide microarray is a promising new technology which could potentially address this need. In this study, we evaluated the usefulness of oligonucleotide resequencing microarrays for identifying GAS and its associated antibiotic resistance markers. We demonstrated an assay platform that combines the use of resequencing DNA microarrays with either random nucleic acid amplification or multiplex PCR for GAS detection. When detecting Streptococcus pyogenes from coded clinical samples, this approach demonstrated an excellent concordance with a more established culture method. To this end, we showed the potential of resequencing microarrays for efficient and accurate detection of GAS and its associated antibiotic resistance markers with the benefit of sequencing information from microarray analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.